drugset / Trial / NCT00216398
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy, safety and patient acceptability of Somatuline Autogel in patients with acromegaly previously treated with octreotide LAR.
Timeline
- Start
- 2004-06
- Primary completion
- 2006-06-22
- Completion
- 2006-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lanreotide | Other / unclassified | — | — |